Tonix Pharmaceuticals stock halted ahead of FDA approval news
CAMBRIDGE, MA— EverQuote , Inc. (NASDAQ:EVER) CEO and President Jayme Mendal recently sold a significant portion of his holdings in the company. According to a filing with the Securities and Exchange Commission, Mendal sold 65,117 shares of the company’s Class A common stock on March 20, 2025. The shares were sold at a weighted average price of $28.07, amounting to a total transaction value of approximately $1.83 million. The transaction comes as EverQuote’s stock has shown remarkable strength, gaining over 40% year-to-date and trading near its 52-week high of $28.50, according to InvestingPro data.
The sale was conducted under a Rule 10b5-1 trading plan, which Mendal adopted on December 17, 2024. Following this transaction, Mendal retains ownership of 619,156 shares in EverQuote. The stock sales were executed at prices ranging from $27.66 to $28.43 per share. Analysts maintain a positive outlook on the company, with price targets ranging from $29 to $38, as revealed by InvestingPro data.
The transactions reflect Mendal’s continued management of his personal investment portfolio in EverQuote, a company known for its innovative approach in the online insurance marketplace sector. The company maintains a "GREAT" financial health score according to InvestingPro, with impressive revenue growth of 74% in the last twelve months. For deeper insights into EverQuote’s financial metrics and growth potential, investors can access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, EverQuote reported strong financial results for the fourth quarter of 2024, surpassing expectations with an earnings per share (EPS) of $0.33 compared to the forecasted $0.19. The company achieved a revenue of $147.5 million, exceeding the anticipated $133.77 million and marking a 165% increase year-over-year. EverQuote’s robust performance was highlighted by a record net income of $12.3 million for the quarter and a full-year revenue of $500 million, a 74% increase over 2023. For the upcoming first quarter of 2025, EverQuote projects revenue between $155 million and $160 million, indicating a 73% year-over-year growth. Needham analysts responded to these results by raising the company’s stock price target to $38 from $30, maintaining a Buy rating. They noted the significant recovery in auto carrier marketing spend and the removal of a potential regulatory challenge as positive factors for EverQuote’s outlook. The analysts also emphasized the potential for earnings to exceed estimates for the fiscal year 2025. These developments reflect a positive sentiment towards EverQuote’s financial health and growth prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.